Surgery | Thrombosis Adviser
Efficacy and safety of non-vitamin K-antagonist oral anticoagulants for retinal vascular diseases in patients with atrial fibrillation: Korean cohort study | Scientific Reports
Antithrombotic Therapy in Patients With Valvular Heart Disease
Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease
Risk and benefit of Anticoagulants in NVAF
Anticoagulant Options in Patients with AF & Valvular Heart Disease
Non–Vitamin K Antagonist Oral Anticoagulants for Mechanical Heart Valves | Circulation
Non–Vitamin K Antagonist Oral Anticoagulants for Mechanical Heart Valves | Circulation
EHRAPresident on Twitter: "15/24 NOACs are the drug of choice for stroke prevention in #Afib. But don't forget: Don't use NOACs in pat with mechanical valves or with moderate-to-severe mitral stenosis! 👀
Home - ICHP KeePosted
Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | Drugs in R&D
Présentation PowerPoint
PDF) Non–Vitamin K Antagonist Oral Anticoagulants for Mechanical Heart Valves: Is the Door Still Open?
Heart valve disease module 7: anti-thrombotic therapy for valvular heart disease - The British Journal of Cardiology
![PDF] The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/74c57c00b0ad8ac59619747393dcee53360763a3/4-Table1-1.png "PDF] The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. | Semantic Scholar")
PDF] The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. | Semantic Scholar
Role of oral anticoagulant (OAC) in Valvular AF patients
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement | JACC: Cardiovascular Interventions
Non–Vitamin K Antagonist Oral Anticoagulants for Mechanical Heart Valves | Circulation
Guideline of atrial fibrillation management
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Journal of the
The Korean Journal of Internal Medicine
Anticoagulation of Patients with Mechanical Heart Valves
JCM | Free Full-Text | Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease
Characteristics of the optimal candidate for mechanical heart valve... | Download Scientific Diagram
Four main groups of patients with AF requiring long-term... | Download Scientific Diagram
